You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The book "Pharmacovigilance" describes the pathway to understand that pharmacovigilance plays a specialized and pivotal role in ensuring ongoing safety of medicinal products. Written in plain English, the book is concise, jargon-free, and facilitates an understanding of fundamentals of pharmacovigilance and explores regulatory aspects involved in pharmacovigilance.
Buy E-Book of Pharmacovigilance (English Edition) Book For B.Pharm 8th Semester of U.P. State Universities
Biopharmaceuticals are derived from biological sources, either live organisms or their active components; nowadays, they are mainly produced by biotechnologies. Biopharmaceuticals are extensively used in the treatment of various diseases such as cardiovascular, metabolic, neurological diseases, cancer, and others for which there are no available therapeutic methods. With the advance of science, biopharmaceuticals have revolutionized the treatment, prevention, and diagnosis of many patients with disabling and life-threatening diseases. Innovative biopharmaceuticals definitely improve the life quality of patients and enhance the effectiveness of the healthcare system. This book encompasses the discovery, production, application, and regulation of biopharmaceuticals to demonstrate their research achievement, prospects, and challenges. We expect the significance of biopharmaceuticals to be revealed and emphasized by this book.
Currently, new health benefits of probiotics have been identified, and new strains with probiotic potential have been discovered and continue to be investigated. Likewise, prebiotics and their interaction with the microbiota have been the focus of research in human and animal health, as well as to counteract zoonotic pathogenic microorganisms. Probiotics and prebiotics can be found in food and are isolated or synthesized to be supplemented as functional ingredients for the benefit of humans or animals. The volume contains thirteen chapters that explain the mechanisms of probiotics, prebiotics, and symbiotics from their interaction with the intestinal microbiota as antimicrobials and immunomodulators and their effect on human and animal health.
This book describes the processes that are involved in the development of new drugs. The authors discuss the history, role of natural products and concept of receptor interactions with regard to the initial stages of drug discovery. In a single, highly readable volume, it outlines the basics of pharmacological screening, drug target identification, and genetics involved in early drug discovery. The final chapters introduce readers to stem therapeutics, pharmacokinetics, pharmacovigilance, and toxicological testing. Given its scope, the book will enable research scholars, professionals and young scientists to understand the key fundamentals of drug discovery, including stereochemistry, pharmacokinetics, clinical trials, statistics and toxicology.
The field of combination product development (products born of the integration of medical devices, biologics, and drugs) is so new that, while literature abounds on each part individually, there are very few publications, including FDA documents, available concerning the unique challenges posed by this nascent but fast-growing area. Providing
Demand for safe and clean water is ever increasing and on the other hand, efforts to recover wasted resources particularly water are also gaining significant importance. Researchers, scientists, innovators, and policymakers throughout the world are investing their time and efforts to build effective and sustainable infrastructure to manage and recover resources from discarded wastes of various states and nature. This book would serve as a guide to researchers, technologists, policymakers as well as students on the various materials stock and methods developed in recent years to address complex pollutants that are difficult to treat or remove with conventional as well as existing water treatment methods.
Smoking was and remains one of the most important public healthcare issues. It is estimated that every year six million people die as a result of tobacco consumption. Several diseases are caused or worsened by smoking: different cancer types, heart disease, stroke, lung diseases and others. In this book we describe the different toxic effects of smoke on the human body in active and in passive smokers. It is also well known that many people who smoke wish to quit, but they rarely succeed. Smoking prevention and cessation are of utmost importance, thus we also describe different strategies and aspects of these issues. We hope that this book will help readers to understand better the effects of smoking and learn about new ideas on how to effectively help other people to stop smoking.
The development of the Chronic Care Model (CCM) for the care of patients with chronic diseases has focused on the integration of taking charge of the patient and his family within primary care. The major critical issues in the implementation of the CCM principles are the non-application of the best practices, defined by EBM guidelines, the lack of care coordination and active follow-up of clinical outcomes, and by inadequately trained patients, who are unable to manage their illnesses. This book focuses on these points: the value of an integrated approach to some chronic conditions, the value of the care coordination across the continuum of the illness, the importance of an evidence-based management, and the enormous value of the patients involvement in the struggle against their conditions, without forgetting the essential role of the caregivers and the community when the diseases become profoundly disabling.